1. Home
  2. VRNS vs ITGR Comparison

VRNS vs ITGR Comparison

Compare VRNS & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varonis Systems Inc.

VRNS

Varonis Systems Inc.

N/A

Current Price

$47.55

Market Cap

3.8B

Sector

Technology

ML Signal

N/A

Logo Integer Holdings Corporation

ITGR

Integer Holdings Corporation

HOLD

Current Price

$95.81

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRNS
ITGR
Founded
2004
1970
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.1B
IPO Year
2013
2000

Fundamental Metrics

Financial Performance
Metric
VRNS
ITGR
Price
$47.55
$95.81
Analyst Decision
Buy
Buy
Analyst Count
21
7
Target Price
$42.75
$91.14
AVG Volume (30 Days)
2.6M
430.5K
Earning Date
04-28-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.48
Revenue
$270,288,000.00
$1,853,637,000.00
Revenue This Year
$18.87
$1.69
Revenue Next Year
$17.77
$6.53
P/E Ratio
N/A
$199.46
Revenue Growth
24.35
7.98
52 Week Low
$19.70
$62.00
52 Week High
$63.90
$116.31

Technical Indicators

Market Signals
Indicator
VRNS
ITGR
Relative Strength Index (RSI) 74.79 53.61
Support Level $31.28 $88.32
Resistance Level $63.90 $95.48
Average True Range (ATR) 2.42 2.85
MACD 0.08 0.21
Stochastic Oscillator 84.25 49.87

Price Performance

Historical Comparison
VRNS
ITGR

About VRNS Varonis Systems Inc.

Varonis Systems is a cybersecurity vendor focused on data privacy and security. The firm is currently undergoing a cloud transition as it weans its on-premises customers over to its cloud products that are delivered as software-as-a-service. The New York-based firm was founded in 2005 and went public in 2014.

About ITGR Integer Holdings Corporation

Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.

Share on Social Networks: